Chee Kong Choo - 29 Oct 2025 SCHEDULE 13D/A Report for CytoMed Therapeutics Limited Ordinary Shares (GDTC)

Filing Manager
Chee Kong Choo
Reporting Manager
Choo Chee Kong
Security
CytoMed Therapeutics Limited Ordinary Shares
Symbol
GDTC
Shares outstanding
11,735,810 shares
Disclosed Ownership
2,587,746 shares
Ownership
22%
Form type
SCHEDULE 13D/A
Filing time
29 Oct 2025, 16:13:56 UTC
Date of event
29 Oct 2025
Previous filing
14 Mar 2025
SEC
View on sec.gov

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Choo Chee Kong 22% 2,587,746 512,436 3,773,291 /s/ Choo Chee Kong Choo Chee Kong / Chairman and Director of CytoMed Therapeutics Limited 0001970632